Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Reclassification Directive: adoption by Commissioners before end of July?

This article was originally published in Clinica

Executive Summary

As Clinica went to press, there was speculation that the European Directive on the reclassification of joint implants, namely hip shoulders and knees, was due to be finally adopted by the EU's College of Commissioners on July 27. Publication in the Official Journal of the European Union will follow, after which member states will have six months to transpose it into their national law. There will then be a transition period of 18 months by the end of which manufacturers will have to comply with the new rules and submit their design dossiers for notified body review.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel